Search

everythinglearnresearchcommunity

for

Search:↓

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

A woman with lupus had rare severe symptoms but improved with treatment.

SLE and DM can coexist but are rare and need careful evaluation.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Oral ulcers are common in SLE patients and often link to other symptoms.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.